| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2005 | Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3) | Chen, CN; Lin, CP; Huang, KK; Chen, WC; Hsieh, HP; Liang, PH ; Hsu, JT | Evid Based Complement Alternat Med 2(2), 209-215 | |||
| 2013 | Peptide-mediated Liposomal Doxorubicin Enhances Drug Delivery Efficiency and Therapeutic Efficacy in Lung Cancer Animal Models | Wu, HC; Chang, DK; Li, PC; Hsieh, HP | ||||
| 2006 | Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of SARS-CoV Main Protease | Lu, IL; Mahindroo, N; Liang, PH ; Peng, YH; Kuo, CJ; Tsai, KC; Hsieh, HP; Chao, YS; Wu, SY | J Med Chem 49, 5154-5161 |
